BSEInsider Trading / SAST26 Sept 2026 · 26 Sept 2026, 08:40 pm

Intimation for Closure of Trading Window

Integrated Proteins Ltd · 519606

✦ AI SummaryResults

Integrated Proteins Ltd has announced the closure of its trading window for dealing in its securities, effective from October 1, 2026, until 48 hours after the conclusion of its Board Meeting to consider and approve unaudited financial results for the quarter ending September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Integrated Proteins Ltd - 519606 - Closure of Trading Window

Attachments (1)

📄

c93bcd11-2a1c-4372-a0e4-7e98ea62e222.pdf

pdf

Download →
View document text
INTEGRATED PROTEINS LIMITED Manek Centre,Office No 218,P N Marg,Jamnagar – 361008, Gujarat,India Phone:9428817400 Email ID:integrated.pl2024@gmail.com Website: www.integratedproteins.com CIN: L62013GJ1992PLC018426 Date: 26.09.2026 Department of Corporate Service BSE Limited Phiroz Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: Intimation for Closure of the Trading Window Scrip Code: 519606 Dear Sir /Madam, Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, and in accordance with the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives, this is to inform that the Trading Window for dealing in the securities of the Company shall remain closed with effect from 1st October,2026 and shall reopen after 48 hours from the conclusion of the Board Meeting to be held for consideration and approval of the Unaudited Financial Results of the Company for the quarter 30th September 2026 (both days inclusive). During the aforesaid period, Promoters, Directors, Key Managerial Personnel, Designated Persons, Employees of the Company, and their immediate relatives are advised not to trade in the shares/securities of the Company. The date of the Board Meeting for consideration and approval of the said financial results shall be intimated separately in due course. We request you to kindly take the above on record. Thanking you, Yours faithfully, For Integrated Proteins Limited Hiren Dhirajlal Shah Managing Director DIN: 09842161